Oncotarget 2017, a Study Links Reduction-Oxidation to Cancer Development

Oxidative stress is caused by lack of balancebetween the process of reactive oxygen species nitrogen species (ROS/RNS) generation and the oxidants defensive mechanism. Recent studies have proven that oxidative stress can cause cancer or lead to its development. It does this by causing molecular damage and interfering with reduction-oxidation (redox) signalling.

Various studies have shown that oxidative stress increases the vulnerability of some cancer sites to risk factors. The studies revealed 20 most common pathways which were grouped into three categories. The studies also found out that cancer transformation causes aerobic glycolysis which then enhances the cancer cell assimilation to hypoxia.

Currently, more studies on the link between redox signalling pathways and cancer development arebeing done. Such studies will help in the development of drugs that target those sites. Those working in this area believe that significant advancement will be maderegarding cancer treatment and prevention shortly.

Oncotarget to Increase Weekly Issues to Two

On Sept. 19, 2017, it was reported that Oncotarget would not only be producing two issues in a week but also make them available on various high-level indexes and archives. Readers will access the publications on PubMed, Scopus, and EMBASE among other prominent indexes. Oncotarget is considering working with the National Library of Medicine to become the only journal that posts an issue to PubMed shortly after online publications.

Octotarget has been able to make scientificresults available to more people faster by working with authoritative scientific indexes and archives. As a result, researchers, medical practitioners, and all people in general, have benefited from this collaboration. The decision to publish two issues in a week is expected to enhance the indexing process.Oncotarget will be publishingthe two issues on every Tuesday and Friday.

About Oncotarget

Oncotarget is a medical journal that publishes studies in cancer research and oncology. In addition, the journal covers other studies such as endocrinology, pathology, age-linked illness, physiology, and immunology. The journal works towards making rapid publication of excellent studies. Oncotarget is published by Impact Journals and was started in 2010. The peer-reviewed open access journal’s editors-in-chief Mikhail Blagosklonny and Andrei Gudkov have extensive knowledge on cancer and other issues related to human health.